149 related articles for article (PubMed ID: 34930387)
21. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
Ma Z; Wang X; He J; Xia J; Li Y
PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
[TBL] [Abstract][Full Text] [Related]
22. CircCERS6 Suppresses the Development of Epithelial Ovarian Cancer Through Mediating miR-630/RASSF8.
Li X; Jiang X; Lu J; Lin Y; Jiang L; Li Y; Wan F; Wang C
Biochem Genet; 2022 Dec; 60(6):2611-2629. PubMed ID: 35676548
[TBL] [Abstract][Full Text] [Related]
23. Songorine suppresses cell growth and metastasis in epithelial ovarian cancer via the Bcl‑2/Bax and GSK3β/β‑catenin signaling pathways.
Zhang H; Dong R; Zhang P; Wang Y
Oncol Rep; 2019 May; 41(5):3069-3079. PubMed ID: 30896826
[TBL] [Abstract][Full Text] [Related]
24. Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/
Liu Y; Li W; Luo J; Wu Y; Xu Y; Chen T; Zhang W; Fu F
Dis Markers; 2021; 2021():3566749. PubMed ID: 34413913
[TBL] [Abstract][Full Text] [Related]
25. The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability.
Petri MH; Laguna-Fernández A; Gonzalez-Diez M; Paulsson-Berne G; Hansson GK; Bäck M
Cardiovasc Res; 2015 Jan; 105(1):65-74. PubMed ID: 25341894
[TBL] [Abstract][Full Text] [Related]
26. CTHRC1 in Ovarian Cancer Promotes M2-Like Polarization of Tumor-Associated Macrophages via Regulation of the STAT6 Signaling Pathway.
Bai Y; Yin K; Su T; Ji F; Zhang S
Onco Targets Ther; 2020; 13():5743-5753. PubMed ID: 32606786
[TBL] [Abstract][Full Text] [Related]
27. RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.
Liu YB; Mei Y; Long J; Zhang Y; Hu DL; Zhou HH
J Exp Clin Cancer Res; 2018 Aug; 37(1):182. PubMed ID: 30075819
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
29. LINC00968 accelerates the progression of epithelial ovarian cancer via mediating the cell cycle progression.
Yao N; Sun JQ; Yu L; Ma L; Guo BQ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4642-4649. PubMed ID: 31210289
[TBL] [Abstract][Full Text] [Related]
30. Extracellular Vesicle-Packaged circATP2B4 Mediates M2 Macrophage Polarization via miR-532-3p/SREBF1 Axis to Promote Epithelial Ovarian Cancer Metastasis.
Wang F; Niu Y; Chen K; Yuan X; Qin Y; Zheng F; Cui Z; Lu W; Wu Y; Xia D
Cancer Immunol Res; 2023 Feb; 11(2):199-216. PubMed ID: 36512324
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
Ge F; Wang C; Wang W; Liu W; Wu B
Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
[TBL] [Abstract][Full Text] [Related]
32. [Effect and mechanism of gene therapy of lentivirus mediated RhoA shRNA on ovarian cancer xenograft in vivo].
Jiang WY; Kang JL; Wang XX; Yang WJ; Nie ML; Zhou C
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):778-83. PubMed ID: 24406137
[TBL] [Abstract][Full Text] [Related]
33. STAT1-Induced Upregulation lncRNA LINC00958 Accelerates the Epithelial Ovarian Cancer Tumorigenesis by Regulating Wnt/
Xie M; Fu Q; Wang PP; Cui YL
Dis Markers; 2021; 2021():1405045. PubMed ID: 34790276
[TBL] [Abstract][Full Text] [Related]
34. Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2.
Li Y; Cai L; Wang H; Wu P; Gu W; Chen Y; Hao H; Tang K; Yi P; Liu M; Miao S; Ye D
Oncogene; 2011 Sep; 30(36):3887-99. PubMed ID: 21499310
[TBL] [Abstract][Full Text] [Related]
35. The activation of microRNA-520h-associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression.
Zhang J; Liu W; Shen F; Ma X; Liu X; Tian F; Zeng W; Xi X; Lin Y
Cell Death Dis; 2018 Aug; 9(9):884. PubMed ID: 30158641
[TBL] [Abstract][Full Text] [Related]
36. The role of S100A14 in epithelial ovarian tumors.
Cho H; Shin HY; Kim S; Kim JS; Chung JY; Chung EJ; Chun KH; Hewitt SM; Kim JH
Oncotarget; 2014 Jun; 5(11):3482-96. PubMed ID: 24939856
[TBL] [Abstract][Full Text] [Related]
37. Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion.
Minopoli M; Botti G; Gigantino V; Ragone C; Sarno S; Motti ML; Scognamiglio G; Greggi S; Scaffa C; Roca MS; Stoppelli MP; Ciliberto G; Losito NS; Carriero MV
J Exp Clin Cancer Res; 2019 Nov; 38(1):459. PubMed ID: 31703596
[TBL] [Abstract][Full Text] [Related]
38. miR-200c overexpression inhibits the invasion and tumorigenicity of epithelial ovarian cancer cells by suppressing lncRNA HOTAIR in mice.
Yang C; Li H; Zhang T; Chu Y; Chen D; Zuo J
J Cell Biochem; 2020 Feb; 121(2):1514-1523. PubMed ID: 31535411
[TBL] [Abstract][Full Text] [Related]
39. VIP modulates human macrophages phenotype via FPRL1 via activation of RhoA-GTPase and PLC pathways.
Harhous Z; Faour WH; El Zein N
Inflamm Res; 2021 Mar; 70(3):309-321. PubMed ID: 33502586
[TBL] [Abstract][Full Text] [Related]
40. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis.
Wang X; Gao S; Song L; Liu M; Sun Z; Liu J
Mol Immunol; 2021 Feb; 130():113-121. PubMed ID: 33308900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]